Status:
COMPLETED
Mobile-enhanced Group CBT for Adolescents at Risk Severe Mood Disorders
Lead Sponsor:
University of California, Los Angeles
Conditions:
Adolescents
Mood Disorders
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
Although cognitive-behavioral therapy (CBT) has shown efficacy in reducing symptoms and rates of mood relapse in adolescents at high risk for severe mood disorders (SMD; i.e., bipolar I/II disorder an...
Eligibility Criteria
Inclusion
- Meet DSM-5 criteria for at least one past major depressive disorder, persistent depressive disorder, or unspecified bipolar disorder
- Be 13-17 years old
- English speaking and able to complete written questionnaires
- Ability to attend pre-determined group session time(s)
- Access to a smartphone to engage with the study app
- Medication usage is acceptable, but not required
Exclusion
- Regular use or current abuse of a psychoactive drug
- Evidence of behavioral problems that are thought to interfere with group treatment
- Suicidality that requires more intensive treatment
- Meeting DSM 5 criteria for bipolar I or II disorder, a psychotic disorder, or significant psychiatric symptoms (e.g., self-injurious behavior) that require more intensive treatment
- Concurrent participation in cognitive-behavioral therapy
- Inability to travel to study sessions and assessments
Key Trial Info
Start Date :
August 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2024
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04887155
Start Date
August 30 2021
End Date
March 15 2024
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Semel Institute
Los Angeles, California, United States, 90095-8353